CLINICAL_TRIALS
trial_result
· 2011-12-14
Clinical Trial Update: Paclitaxel in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer [Phase 2]
Summary
A completed Phase 2 clinical trial evaluating paclitaxel for unresectable locally advanced or metastatic pancreatic cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Theradex | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED